For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab100575? Please let us know so that we can cite the reference in this datasheet.
ab100575 has been referenced in 1 publication.
- Giles KM et al. Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib. Mol Cancer Ther 12:2541-58 (2013).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"